Showing results (71-80 of 85) with videos related to
Sort By:
Pageof 9
Oncotarget|May 1, 2018
Glioblastoma-specific anti-TUFM nanobody for <i>in-vitro</i> immunoimaging and cancer stem cell targetingNeja Samec, Ivana Jovcevska, Jure Stojan, et al.Molecular Microbiology|August 4, 2011
The versatility of the fungal cytochrome P450 monooxygenase system is instrumental in xenobiotic detoxificationLjerka Lah, Barbara Podobnik, Metka Novak, et al.Journal of Affective Disorders|July 30, 2010
The association between brain-derived neurotrophic factor polymorphism (BDNF Val66Met) and suicidePeter Pregelj, Gordana Nedic, Alja Videtič Paska, et al.Scientific Reports|August 16, 2022
Inflammatory landscape in Xeroderma pigmentosum patients with cutaneous melanomaAsma Chikhaoui, Meriem Jones, Tadeja Režen, et al.Journal of Chemical Information and Modeling|October 25, 2012
Virtual screening yields inhibitors of novel antifungal drug target, benzoate 4-monooxygenaseSabina Berne, Barbara Podobnik, Neja Zupanec, et al.Oncotarget|May 13, 2017
Differentially expressed proteins in glioblastoma multiforme identified with a nanobody-based anti-proteome approach and confirmed by OncoFinder as possible tumor-class predictive biomarker candidatesIvana Jovčevska, Neja Zupanec, Žiga Urlep, et al.Molecules (Basel, Switzerland)|September 10, 2021
TRIM28 Selective Nanobody Reduces Glioblastoma Stem Cell InvasionAndrej Porčnik, Metka Novak, Barbara Breznik, et al.Cancers|February 11, 2023
Anti-Vimentin Nanobody Decreases Glioblastoma Cell Invasion In Vitro and In VivoAlja Zottel, Metka Novak, Neja Šamec, et al.International Journal of Molecular Sciences|November 14, 2020
Analysis of miR-9-5p, miR-124-3p, miR-21-5p, miR-138-5p, and miR-1-3p in Glioblastoma Cell Lines and Extracellular VesiclesAlja Zottel, Neja Šamec, Ana Kump, et al.Plos One|November 25, 2014
TRIM28 and β-actin identified via nanobody-based reverse proteomics approach as possible human glioblastoma biomarkersIvana Jovčevska, Neja Zupanec, Nina Kočevar, et al.Pageof 9